Diagnostic anti-[acute respiratory infectious diseases] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays

Acute respiratory tract infection (ARTI) is very common, with most people experiencing at least one episode of ARTI each year [1]. ARTI includes upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI). The common cold and influenza are the most common ARTIs globally; the highest rate occurs during the winter months in temperate areas with little seasonal change in tropical regions [2]. During epidemic months, influenza can affect 20% to 50% of people worldwide [2]. Bronchitis and pneumonia are the two most common infections of the lower airways, and mortality due to LRTI is high [3]. In 2015, more than 2.8 million deaths worldwide were due to LRTI; children and the elderly are the most affected groups [3].Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-acute respiratory infectious diseases monoclonal antibody for rapid test kit of acute respiratory infectious diseases to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-ARTI-1Ab-1mg	1mg	1953
GMP-ARTI-1Ab-10mg	10mg	13671
GMP-ARTI-1Ab-100mg	100mg	95697
GMP-ARTI-1Ab-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Antigen & Antibody Name	Mouse anti-acute respiratory infectious diseases monoclonal antibody
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in[acute respiratory infectious diseases)] level test in human infectious disease diagnositcs.
Tag	mFc
Products description	Acute respiratory tract infection (ARTI) is very common, with most people experiencing at least one episode of ARTI each year [1]. ARTI includes upper respiratory tract infection (URTI) and lower respiratory tract infection (LRTI). The common cold and influenza are the most common ARTIs globally; the highest rate occurs during the winter months in temperate areas with little seasonal change in tropical regions [2]. During epidemic months, influenza can affect 20% to 50% of people worldwide [2]. Bronchitis and pneumonia are the two most common infections of the lower airways, and mortality due to LRTI is high [3]. In 2015, more than 2.8 million deaths worldwide were due to LRTI; children and the elderly are the most affected groups [3].
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.